Elevance Health (ELV): CFO sold ~$724K
Mark Kaye, CFO at Elevance Health, sold ~$724K of Elevance Health shares.
- ~$724K
- Approx. value · 1,660 sh @ $436.20
- 28K
- Holds after · shares reported
- Traded
- Oct 22, 2026
- Filed
- Oct 23, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
- Oct 22, 2026 · this disclosureInsiderCFO sold ~$724K of ELV shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Elevance Health
For Elevance Health, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELV page.
Other recent filings by Mark Kaye, EVP & CFO
- SEC Form 4 at Elevance Health (ELV)Oct 23, 2026
- SEC Form 4 at Elevance Health (ELV)Oct 23, 2026
- SEC Form 4 at Elevance Health (ELV)Oct 23, 2026
- SEC Form 4 at Elevance Health (ELV)Oct 23, 2026
- SEC Form 4 at Elevance Health (ELV)Oct 23, 2026
The full history of Mark Kaye, EVP & CFO is on the profile page.
How this filing works
Explore the data
Other disclosures at Elevance Health
- SEC Form 4Nov 6, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 4Oct 23, 2026
- SEC Form 4Oct 23, 2026
- SEC Form 4Oct 23, 2026
- SEC Form 4Oct 23, 2026
Everything OQRO holds on this company is on its ELV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
